Acyloxyacyl hydrolase regulates voiding activity

Am J Physiol Renal Physiol. 2020 Apr 1;318(4):F1006-F1016. doi: 10.1152/ajprenal.00442.2019. Epub 2020 Jan 31.

Abstract

Corticotropin-releasing factor (CRF) regulates diverse physiological functions, including bladder control. We recently reported that Crf expression is under genetic control of Aoah, the locus encoding acyloxyacyl hydrolase (AOAH), suggesting that AOAH may also modulate voiding. Here, we examined the role of AOAH in bladder function. AOAH-deficient mice exhibited enlarged bladders relative to wild-type mice and had decreased voiding frequency and increased void volumes. AOAH-deficient mice had increased nonvoiding contractions and increased peak voiding pressure in awake cystometry. AOAH-deficient mice also exhibited increased bladder permeability and higher neuronal firing rates of bladder afferents in response to stretch. In wild-type mice, AOAH was expressed in bladder projecting neurons and colocalized in CRF-expressing neurons in Barrington's nucleus, an important brain area for voiding behavior, and Crf was elevated in Barrington's nucleus of AOAH-deficient mice. We had previously identified aryl hydrocarbon receptor (AhR) and peroxisome proliferator-activated receptor-γ as transcriptional regulators of Crf, and conditional knockout of AhR or peroxisome proliferator-activated receptor-γ in Crf-expressing cells restored normal voiding in AOAH-deficient mice. Finally, an AhR antagonist improved voiding in AOAH-deficient mice. Together, these data demonstrate that AOAH regulates bladder function and that the AOAH-Crf axis is a therapeutic target for treating voiding dysfunction.

Keywords: acyloxyacyl hydrolase; bladder; corticotrophin-releasing hormone; corticotropin-releasing factor; micturition.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Azo Compounds / pharmacology
  • Barrington's Nucleus / metabolism
  • Basic Helix-Loop-Helix Transcription Factors / antagonists & inhibitors
  • Basic Helix-Loop-Helix Transcription Factors / genetics
  • Basic Helix-Loop-Helix Transcription Factors / metabolism
  • Carboxylic Ester Hydrolases / deficiency
  • Carboxylic Ester Hydrolases / genetics
  • Carboxylic Ester Hydrolases / metabolism*
  • Corticotropin-Releasing Hormone / metabolism
  • Female
  • Male
  • Mice, Inbred C57BL
  • Muscle Contraction
  • Neurons / drug effects
  • Neurons / enzymology*
  • PPAR gamma / genetics
  • PPAR gamma / metabolism
  • Pressure
  • Pyrazoles / pharmacology
  • Receptors, Aryl Hydrocarbon / antagonists & inhibitors
  • Receptors, Aryl Hydrocarbon / genetics
  • Receptors, Aryl Hydrocarbon / metabolism
  • Urinary Bladder / drug effects
  • Urinary Bladder / innervation*
  • Urination Disorders / drug therapy
  • Urination Disorders / enzymology*
  • Urination Disorders / genetics
  • Urination Disorders / physiopathology
  • Urination* / drug effects
  • Urodynamics* / drug effects

Substances

  • 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide
  • Ahr protein, mouse
  • Azo Compounds
  • Basic Helix-Loop-Helix Transcription Factors
  • PPAR gamma
  • Pparg protein, mouse
  • Pyrazoles
  • Receptors, Aryl Hydrocarbon
  • Corticotropin-Releasing Hormone
  • Carboxylic Ester Hydrolases
  • acyloxyacyl hydrolase